Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
Tommy Rampling, Katie Ewer, Georgina Bowyer, et al.
The Journal of Infectious Diseases (2016) Vol. 214, Iss. 5, pp. 772-781
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naïve mice
Taylor B. Poston, Jenna Girardi, A Grace Polson, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 5, pp. 1005-1018
Open Access | Times Cited: 5
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
Navin Venkatraman, Alfred B. Tiono, Georgina Bowyer, et al.
The Lancet Microbe (2025), pp. 100868-100868
Open Access
RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
Carolyn M. Nielsen, Johan Vekemans, Marc Lievens, et al.
Vaccine (2018) Vol. 36, Iss. 12, pp. 1637-1642
Open Access | Times Cited: 44
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M. Bliss, Georgina Bowyer, Nicholas Anagnostou, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 41
Vaccination With Sporozoites: Models and Correlates of Protection
Yun Shan Goh, Daniel McGuire, Laurent Rénia
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 41
Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens
S. Moses Dennison, Matthew Reichartz, Kelly E. Seaton, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 4, pp. 1315-1326
Open Access | Times Cited: 38
Correlates of malaria vaccine efficacy
Danielle I. Stanisic, Matthew B. B. McCall
Expert Review of Vaccines (2021) Vol. 20, Iss. 2, pp. 143-161
Open Access | Times Cited: 30
Monoclonal antibodies for malaria prevention
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1810-1821
Open Access | Times Cited: 20
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18–45 years: an open-label, partially blinded, phase 1–2a controlled human malaria infection study
Navin Venkatraman, Daniel Silman, Duncan Bellamy, et al.
The Lancet Microbe (2025), pp. 100867-100867
Closed Access
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
Muralimanohara S. T. Murala, Vivek Gairola, Ekramy E. Sayedahmed, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 406-406
Open Access
Malaria parasite LIMP protein regulates sporozoite gliding motility and infectivity in mosquito and mammalian hosts
Jorge M. Santos, Saskia Egarter, Vanessa Zuzarte‐Luís, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 37
CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
Georgina Bowyer, Amy Grobbelaar, Tommy Rampling, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 37
Malaria vaccines in the eradication era: current status and future perspectives
Kirsty Wilson, Katie L. Flanagan, Monica D. Prakash, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 2, pp. 133-151
Closed Access | Times Cited: 35
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
Tarsila Mendes de Camargo, Elisângela Oliveira de Freitas, Alba Marina Gimenez, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
Erwan Atcheson, Karolis Bauza, Ahmed M. Salman, et al.
Infection and Immunity (2018) Vol. 86, Iss. 9
Open Access | Times Cited: 33
Tissues: the unexplored frontier of antibody mediated immunity
Nicholas E. Webb, Biana Bernshtein, Galit Alter
Current Opinion in Virology (2021) Vol. 47, pp. 52-67
Open Access | Times Cited: 26
Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies
Jishnu Das, Jonathan K. Fallon, Timothy C. Yu, et al.
Med (2021) Vol. 2, Iss. 11, pp. 1269-1286.e9
Closed Access | Times Cited: 25
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
Wen-Chien Wang, Ekramy E. Sayedahmed, Suresh K. Mittal
Viruses (2022) Vol. 14, Iss. 12, pp. 2727-2727
Open Access | Times Cited: 17
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™
Navin Venkatraman, Nicholas Anagnostou, Carly M. Bliss, et al.
Vaccine (2017) Vol. 35, Iss. 45, pp. 6208-6217
Closed Access | Times Cited: 31
Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
Peter Abbink, Marinela Kirilova, Michael Boyd, et al.
Journal of Virology (2018) Vol. 92, Iss. 6
Open Access | Times Cited: 31
Correlating efficacy and immunogenicity in malaria vaccine trials
Matthew B. B. McCall, Peter G. Kremsner, Benjamin Mordmüller
Seminars in Immunology (2018) Vol. 39, pp. 52-64
Closed Access | Times Cited: 30
InvestigatingBordetella pertussiscolonisation and immunity: protocol for an inpatient controlled human infection model
Hans de Graaf, Diane Gbesemete, Andrew Gorringe, et al.
BMJ Open (2017) Vol. 7, Iss. 10, pp. e018594-e018594
Open Access | Times Cited: 29
Adenovirus—Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes
Coraline Chéneau, Eric J. Kremer
Viruses (2020) Vol. 12, Iss. 12, pp. 1351-1351
Open Access | Times Cited: 24
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection
Mingxi Li, Jingao Guo, Shuaiyao Lu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
The Antibody Response to Plasmodium falciparum: Cues for Vaccine Design and the Discovery of Receptor-Based Antibodies
Joshua Tan, Luca Piccoli, Antonio Lanzavecchia
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 225-246
Open Access | Times Cited: 26

Scroll to top